This editorial discusses the need for personalized glycemic strategies to enhance time in range in diabetes patients, suggesting a vital connection to improved life quality.
Key Points
The aim is to explore how better management of time in range (TIR) can lead to longer, healthier lives for individuals with diabetes.
Review of landmark diabetes studies including DCCT and UKPDS
Analysis of intensive glycemic control outcomes
Evaluation of continuous glucose monitoring technology benefits
Improved TIR correlates with lower all-cause mortality among diabetes patients
Intensive glycemic control can lead to severe hypoglycemia and increased cardiovascular risks
Technological advancements in CGM enhance daily glucose monitoring and reduce hypoglycemic events